Plant-derived functional foods are gaining considerable attention due to their safety and
therapeutic potentials. Research on plant-based functional foods presents several …

Polyphenols are found ubiquitously in plants and their regular consumption has been
associated with a reduced risk of a number of chronic diseases, including cancer …

Transcatheter arterial chemoembolization (TACE) offers a survival benefit to patients with
intermediate hepatocellular carcinoma (HCC). A widely accepted TACE regimen includes …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide. Only 30%-40% of the patients with HCC are eligible for curative treatments …

Hepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in
adults and the third most common cause of cancer death worldwide. The incidence of HCC …

A connection between inflammation and cancer has been long suspected. Epidemiological
studies have established that many tumors occur in association with chronic infectious …

Hepatocellular carcinoma (HCC) is the third cause of cancer‐related death worldwide.
Curative options for HCC are limited and exclusively available for patients carrying an early …

The incidence of hepatocellular carcinoma (HCC) and HCC-related deaths has increased
over the last few decades. There are several risk factors of HCC such as viral hepatitis (B …

Relative to normal tissues, tumor microcirculation exhibits high structural and functional
heterogeneity leading to hypoxic regions and impairing treatment efficacy. Here …

Hepatocellular carcinoma (HCC) is the fifth most frequent cancer and the third cause of
cancer‐related mortality worldwide. The primary risk factor for HCC is liver cirrhosis …